Consenso Intersociedades para el manejo de infecciones respiratorias: bronquitis aguda y enfermedad pulmonar obstructiva crónica.

Lopardo Gustavo; Pensotti Claudia; Scapellato Pablo; Caberlotto Oscar; Calmaggi Aníbal; Clara Liliana; Klein Manuel; Levy Hara Gabriel; López Furst María J; Mykietiuk Analía; Pryluka Daniel; Rial María J; Vujacich Claudia; Yahni Diego.
Medicina (B Aires) ; 73(2): 163-73, 2013.
Artículo en Español | BINACIS | ID: bin-133144

Documentos relacionados

  1. p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics.
  2. Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.
  3. Precision Approaches to Chronic Obstructive Pulmonary Disease Management.
  4. How might endotyping guide chronic obstructive pulmonary disease treatment? Current understanding, knowledge gaps and future research needs.
  5. Joint longitudinal model-based meta-analysis of FEV<sub>1</sub> and exacerbation rate in randomized COPD trials.
  6. [What have we learned from the German COPD cohort COSYCONET and where do we go from here?]
  7. [The research progress of high altitude environment-associated chronic obstructive pulmonary disease and therapeutic drugs].
  8. The Role of Bioactive Small Molecules in COPD Pathogenesis.
  9. Using UPLC-LTQ-Orbitrap-MS and HPLC-CAD to Identify Impurities in Cycloastragenol, Which Is a Pre-Clinical Candidate for COPD.
  10. Bronchoscopic interventions for chronic bronchitis.